Who owns NEUMORA THERAPEUTICS INC.?
- Ticker: NMRA
- CUSIP Number: 640979100
Tip: Access positions for across all investors
Analyze quarterly positions in Neumora Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neumora Therapeutics stock
Who bought or sold NEUMORA THERAPEUTICS INC. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Softbank Group Corp | 7.6M | $130M | 0% | Dec 2023 |
|
| FMR | 7.5M | $103M | 33% | Mar 2024 |
|
| MIC Capital Management UK | 4.5M | $61M | 0% | Mar 2024 |
|
| T. Rowe Price Investment Management | 3.6M | $49M | 100% | Mar 2024 |
|
| ICONIQ Capital | 3.4M | $47M | 100% | Mar 2024 |
|
| Wellcome Trust Limited, as Trustee of the Wellcome Trust | 3.3M | $46M | 0% | Mar 2024 |
|
| Artal Group | 2.9M | $40M | 15% | Mar 2024 |
|
| EcoR1 Capital | 2.1M | $29M | 0% | Mar 2024 |
|
| Johnson & Johnson | 1.8M | $25M | 103% | Mar 2024 |
|
| Citadel Advisors | 1.8M | $25M | -1% | Mar 2024 |
|
| Avidity Partners Management | 1.8M | $25M | -10% | Mar 2024 |
|
| Hillhouse Capital Advisors | 1.7M | $29M | 0% | Dec 2023 |
|
| OrbiMed Advisors | 1.5M | $21M | 0% | Mar 2024 |
|
| BlackRock | 986k | $14M | 3842% | Mar 2024 |
|
| Soros Capital Management | 904k | $12M | 54% | Mar 2024 |
|
| T. Rowe Price Associates | 753k | $10M | 100% | Mar 2024 |
|
| Balyasny Asset Management | 688k | $9.5M | 100% | Mar 2024 |
|
| Rock Springs Capital Management | 646k | $8.9M | 100% | Mar 2024 |
|
| Baker Bros. Advisors | 634k | $8.7M | 100% | Mar 2024 |
|
| Geode Capital Management | 452k | $6.2M | 270% | Mar 2024 |
|
| Logos Global Management | 382k | $6.2M | 0% | Mar 2024 |
|
| Vanguard Group | 334k | $4.6M | -12% | Mar 2024 |
|
| Addis & Hill | 315k | $4.2M | 100% | Mar 2024 |
|
| Pier Capital | 249k | $3.4M | 100% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 249k | $3.4M | -5% | Mar 2024 |
|
| Callan Capital | 205k | $2.8M | 100% | Mar 2024 |
|
| LMR Partners | 188k | $2.6M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 163k | $2.2M | -73% | Mar 2024 |
|
| Ensign Peak Advisors | 150k | $2.1M | 0% | Mar 2024 |
|
| Kennedy Capital Management | 137k | $1.9M | 100% | Mar 2024 |
|
| Millennium Management | 137k | $1.9M | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 125k | $1.7M | -4% | Mar 2024 |
|
| Northern Trust | 121k | $1.7M | 100% | Mar 2024 |
|
| TD Asset Management | 110k | $1.5M | 100% | Mar 2024 |
|
| ALPS Advisors | 106k | $1.8M | 100% | Dec 2023 |
|
| Auour Investments | 105k | $1.4M | 100% | Mar 2024 |
|
| Hudson Bay Capital Management | 98k | $1.4M | 100% | Mar 2024 |
|
| Ieq Capital | 83k | $1.1M | 100% | Mar 2024 |
|
| Citigroup | 69k | $941k | 1091% | Mar 2024 |
|
| Landscape Capital Management | 66k | $907k | 100% | Mar 2024 |
|
| Morgan Stanley | 65k | $899k | 16244% | Mar 2024 |
|
| Royal Bank of Canada | 51k | $717k | 927% | Mar 2024 |
|
| Bank of New York Mellon | 41k | $564k | -9% | Mar 2024 |
|
| Jane Street | 41k | $560k | -54% | Mar 2024 |
|
| Wells Fargo & Company | 35k | $481k | 28% | Mar 2024 |
|
| Jpmorgan Chase & Co | 35k | $477k | -43% | Mar 2024 |
|
| Susquehanna International | 33k | $451k | 14% | Mar 2024 |
|
| GSA Capital Partners | 30k | $410k | -36% | Mar 2024 |
|
| Wexford Capital | 29k | $401k | 100% | Mar 2024 |
|
| Windmill Hill Asset Management | 26k | $359k | 100% | Mar 2024 |
|
| UBS Group | 25k | $348k | 9775% | Mar 2024 |
|
| Bank of America Corporation | 22k | $304k | 46% | Mar 2024 |
|
| Verition Fund Management | 22k | $303k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 21k | $285k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 18k | $251k | -15% | Mar 2024 |
|
| Rhumbline Advisers | 18k | $241k | 12% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 13k | $173k | 100% | Mar 2024 |
|
| XTX Topco | 12k | $170k | 100% | Mar 2024 |
|
| Barclays | 10k | $143k | -49% | Mar 2024 |
|
| Legacy Private Trust | 10k | $138k | 0% | Mar 2024 |
|
| Oxford Asset Management | 10k | $138k | 100% | Mar 2024 |
|
| MetLife Investment Advisors | 8.5k | $145k | 100% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 8.0k | $110k | 0% | Mar 2024 |
|
| American International | 7.4k | $126k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 7.0k | $96k | 1% | Mar 2024 |
|
| Virtus ETF Advisers | 5.9k | $81k | -6% | Mar 2024 |
|
| Simplex Trading | 2.8k | $39k | 100% | Mar 2024 |
|
| Tower Research Capital | 2.6k | $36k | 100% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.2k | $30k | -31% | Mar 2024 |
|
| Summit Investment Advisors | 1.5k | $21k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 1.5k | $21k | 100% | Mar 2024 |
|
| Legal & General Group | 1.4k | $20k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 921.00 | $16k | 100% | Dec 2023 |
|
| Amalgamated Bank | 508.00 | $7.0k | -70% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 174.00 | $2.4k | 100% | Mar 2024 |
|
| NISA Investment Advisors | 12.00 | $165.000000 | 100% | Mar 2024 |
|
| GAMMA Investing | 9.00 | $124.000200 | 100% | Mar 2024 |
|
| Covestor | 8.00 | $0 | 100% | Mar 2024 |
|
| Pnc Financial Services | 5.00 | $69.000000 | 100% | Mar 2024 |
|
| CWM | 3.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Neumora Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alphabet | Dec 2023 | 405k | $6.9M |
| GMT Capital Corp | Dec 2023 | 141k | $2.4M |
| Scoggin | Dec 2023 | 125k | $2.1M |
| Cormorant Asset Management | Dec 2023 | 92k | $1.6M |
| Norges Bank Investment Management | Dec 2023 | 50k | $853k |
| Greenland Capital Management | Sep 2023 | 48k | $672k |
| First Trust Advisors | Sep 2023 | 27k | $378k |
| SG Americas Securities | Dec 2023 | 6.3k | $108k |
| Advisory Services Network | Dec 2023 | 200.00 | $3.4k |
| Quarry | Dec 2023 | 50.00 | $853.000000 |